Block S L
Kentucky Pediatric Research, Bardstown, USA.
Arch Fam Med. 1999 Jan-Feb;8(1):68-78. doi: 10.1001/archfami.8.1.68.
Acute otitis media is the most common bacterial infection in pediatric patients. The predominant pathogens of acute otitis media are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Traditionally, amoxicillin has been the first-line therapeutic choice for patients with uncomplicated acute otitis media. However, with the increasing isolation of beta-lactamase-producing organisms and penicillin-resistant S pneumoniae, the frequency of amoxicillin treatment failures also appears to be increasing. Several issues should be considered when alternative antibiotics are selected to treat amoxicillin failures, such as the most likely pathogens with their susceptibility patterns, and antibiotic issues including clinical efficacy for specific pathogens, adverse reactions, palatability, dosing schedules, and cost. Consequently, enhanced beta-lactamase stability, activity against penicillin-resistant S pneumoniae, and once- or twice-daily dosing regimens must be considered when antibiotics are chosen for patients in whom amoxicillin therapy has failed.
急性中耳炎是儿科患者中最常见的细菌感染。急性中耳炎的主要病原体是肺炎链球菌、流感嗜血杆菌和卡他莫拉菌。传统上,阿莫西林一直是无并发症急性中耳炎患者的一线治疗选择。然而,随着产β-内酰胺酶 organisms 和耐青霉素肺炎链球菌的分离增加,阿莫西林治疗失败的频率似乎也在增加。在选择替代抗生素治疗阿莫西林治疗失败时,应考虑几个问题,例如最可能的病原体及其药敏模式,以及抗生素问题,包括对特定病原体的临床疗效、不良反应、适口性、给药方案和成本。因此,当为阿莫西林治疗失败的患者选择抗生素时,必须考虑增强的β-内酰胺酶稳定性、对耐青霉素肺炎链球菌的活性以及每日一次或两次的给药方案。